Crescendo Bioscience To Feature New Data On Vectra DA At 2014 ACR Meeting

By: via Benzinga
Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (Nasdaq: MYGN), today announced that new data on Vectra® DA ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.